(Q85359306)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23126020%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

title

Canadian Guidelines on Parkinson's Disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23126020%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference

David Grimes

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23126020%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Joyce Gordon

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23126020%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Barbara Snelgrove

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23126020%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Ivy Lim-Carter

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23126020%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Edward Fon

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23126020%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Wayne Martin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23126020%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Marguerite Wieler

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23126020%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Oksana Suchowersky

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23126020%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Alex Rajput

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23126020%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Anne L Lafontaine

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23126020%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Jon Stoessl

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23126020%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Elena Moro

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23126020%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Kerrie Schoffer

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23126020%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Janis Miyasaki

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23126020%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Doug Hobson

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23126020%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Minoo Mahmoudi

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23126020%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Susan Fox

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23126020%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Ron Postuma

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23126020%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Hrishikesh Kumar

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23126020%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Mandar Jog

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23126020%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Canadian Nourological Sciences Federation

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23126020%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

publication date

1 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23126020%20AND%20SRC:MED&resulttype=core&format=json

Canadian Journal of Neurological Sciences

17 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23126020%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23126020%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

issue

4 Suppl 4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23126020%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

page(s)

S1-30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23126020%20AND%20SRC:MED&resulttype=core&format=json

Pharmacotherapy for neurogenic detrusor overactivity

17 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

A systematic review of non-pharmacological therapies for sleep problems in later life

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Bowel movement frequency in late-life and incidental Lewy bodies

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Treatment of dysautonomia associated with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Practice Parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Orthostatic hypotension as an early finding in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Nonmotor manifestations of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Sleep disorders in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Melatonin for sleep disturbances in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Ipratropium bromide spray as treatment for sialorrhea in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Non-motor symptoms of Parkinson's disease: diagnosis and management

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Symptoms of autonomic failure in Parkinson's disease: prevalence and impact on daily life

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Treatment of insomnia in Parkinson's disease: a controlled trial of eszopiclone and placebo

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Excessive daytime sleepiness in parkinsonism

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

A double-blind comparison of galantamine hydrobromide ER and placebo in Parkinson disease

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

A randomized trial of deep-brain stimulation for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Rater-blinded, prospective comparison: quetiapine versus clozapine for Parkinson's disease psychosis

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Multicenter study on deep brain stimulation in Parkinson's disease: an independent assessment of reported adverse events at 4 years.

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

The impact of depressive symptoms in early Parkinson disease

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Dopamine agonist-triggered pathological behaviors: surveillance in the PD clinic reveals high frequencies

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Is obstructive sleep apnea a problem in Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Treatment of restless legs syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

A double-blind, delayed-start trial of rasagiline in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Effect of quetiapine in psychotic Parkinson's disease patients: a double-blind labeled study of 3 months' duration.

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Update on the pharmacology of REM sleep behavior disorder

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Parkinson’s disease psychosis 2010: A review article

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population?

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Treatment of sialorrhoea in patients with Parkinson's disease: best current evidence

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

A randomized controlled trial of quetiapine for psychosis in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

How valid is the clinical diagnosis of Parkinson's disease in the community?

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Major nutritional issues in the management of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Sublingual atropine for sialorrhea secondary to parkinsonism: a pilot study.

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Parkinson's disease in the elderly: response to and optimal spacing of night time dosing with levodopa

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Insomnia in patients with neurodegenerative conditions.

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Long-term evaluation of deep brain stimulation of the thalamus

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

A controlled trial of antidepressants in patients with Parkinson disease and depression

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Body weight in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Multicentre European study of thalamic stimulation for parkinsonian tremor: a 6 year follow-up

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Randomized study of sertraline and low-dose amitriptyline in patients with Parkinson's disease and depression: effect on quality of life.

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Timing of treatment initiation in Parkinson's disease: a need for reappraisal?

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS031716710001516X

7 January 2021

10.1017/S031716710001516X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23126020%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference